Recent studies have demonstrated that activation of c-Met can modulate the redox protective nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) and downregulate reactive oxygen species (ROS), eventually inhibiting the death of cancer cells [6]. The gene discussed is MET; the disease is cancer.